These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1348240

  • 1. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
    Reubi JC, Waser B, van Hagen M, Lamberts SW, Krenning EP, Gebbers JO, Laissue JA.
    Int J Cancer; 1992 Apr 01; 50(6):895-900. PubMed ID: 1348240
    [Abstract] [Full Text] [Related]

  • 2. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
    Bakker WH, Albert R, Bruns C, Breeman WA, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW.
    Life Sci; 1991 Apr 01; 49(22):1583-91. PubMed ID: 1658515
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
    Ferone D, van Hagen MP, Kwekkeboom DJ, van Koetsveld PM, Mooy DM, Lichtenauer-Kaligis E, Schönbrunn A, Colao A, Lamberts SW, Hofland LJ.
    J Clin Endocrinol Metab; 2000 Apr 01; 85(4):1719-26. PubMed ID: 10770220
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH, Visser-Wisselaar HA, Rutteman GR, van Rijk PP, van Dongen AJ, Voorhout G, van den Ingh TS, Hofland LJ, Lamberts SW.
    J Nucl Med; 1997 Jul 01; 38(7):1036-42. PubMed ID: 9225787
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
    van den Anker-Lugtenburg PJ, Heule F, Vanhagen PM, van Joost T, Oei HY, Löwenberg B, Krenning EP.
    J Am Acad Dermatol; 1996 Jun 01; 34(6):985-93. PubMed ID: 8647992
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin receptors in malignant lymphomas: targets for radiotherapy?
    Dalm VA, Hofland LJ, Mooy CM, Waaijers MA, van Koetsveld PM, Langerak AW, Staal FT, van der Lely AJ, Lamberts SW, van Hagen MP.
    J Nucl Med; 2004 Jan 01; 45(1):8-16. PubMed ID: 14734660
    [Abstract] [Full Text] [Related]

  • 7. Somatostatin analogue scintigraphy in granulomatous diseases.
    Vanhagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, Laissue I, Hoogstede HC, Lamberts SW.
    Eur J Nucl Med; 1994 Jun 01; 21(6):497-502. PubMed ID: 8082663
    [Abstract] [Full Text] [Related]

  • 8. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ.
    J Nucl Med; 1995 Jan 01; 36(1):13-8. PubMed ID: 7799065
    [Abstract] [Full Text] [Related]

  • 9. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
    Bakker WH, Krenning EP, Reubi JC, Breeman WA, Setyono-Han B, de Jong M, Kooij PP, Bruns C, van Hagen PM, Marbach P.
    Life Sci; 1991 Jan 01; 49(22):1593-601. PubMed ID: 1658516
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Somatostatin receptor imaging in intracranial tumours.
    Schmidt M, Scheidhauer K, Luyken C, Voth E, Hildebrandt G, Klug N, Schicha H.
    Eur J Nucl Med; 1998 Jul 01; 25(7):675-86. PubMed ID: 9662588
    [Abstract] [Full Text] [Related]

  • 14. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA.
    J Nucl Med; 2003 Aug 01; 44(8):1315-21. PubMed ID: 12902423
    [Abstract] [Full Text] [Related]

  • 15. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SW.
    Eur J Nucl Med; 1994 Apr 01; 21(4):328-35. PubMed ID: 7911760
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 111In-octreotide scintigraphy in oncology.
    Krenning EP, Kwekkeboom DJ, Reubi JC, Van Hagen PM, van Eijck CH, Oei HY, Lamberts SW.
    Metabolism; 1992 Sep 01; 41(9 Suppl 2):83-6. PubMed ID: 1355591
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver.
    Slooter GD, Breeman WA, Marquet RL, Krenning EP, van Eijck CH.
    Int J Cancer; 1999 May 31; 81(5):767-71. PubMed ID: 10328231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.